Skip to content
10-Q

Quarterly Report

agilon health, inc. AGL

0001628280-25-048839

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 414.58M sh
Shares Diluted Q3 2025 · Sep 30, 2025 414.47M sh
Shares Diluted Q3 2025 · Sep 30, 2025 413.75M sh
Shares Diluted Q3 2025 · Sep 30, 2024 411.59M sh
Shares Diluted Q3 2025 · Sep 30, 2024 410.6M sh
Capex Q3 2025 · Sep 30, 2025 $10.27M
Capex Q3 2025 · Sep 30, 2024 $9.99M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$85.23M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$74.2M
Long Term Debt Q3 2025 · Sep 30, 2025 $0
Long Term Debt Q3 2025 · Dec 31, 2024 $34.9M
Short Term Debt Q3 2025 · Sep 30, 2025 $34.97M
Short Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $171.68M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $188.23M
Current Liabilities Q3 2025 · Sep 30, 2025 $1.24B
Current Liabilities Q3 2025 · Dec 31, 2024 $1.15B
Total Liabilities Q3 2025 · Sep 30, 2025 $1.29B
Total Liabilities Q3 2025 · Dec 31, 2024 $1.26B
Current Assets Q3 2025 · Sep 30, 2025 $1.34B
Current Assets Q3 2025 · Dec 31, 2024 $1.46B
Total Assets Q3 2025 · Sep 30, 2025 $1.6B
Total Assets Q3 2025 · Dec 31, 2024 $1.73B
Sga Expense Q3 2025 · Sep 30, 2025 $56.2M
Sga Expense Q3 2025 · Sep 30, 2025 $178.44M
Sga Expense Q3 2025 · Sep 30, 2024 $63.12M
Sga Expense Q3 2025 · Sep 30, 2024 $209.16M
Net Income Q3 2025 · Sep 30, 2025 −$110.21M
Net Income Q3 2025 · Sep 30, 2025 −$202.47M
Net Income Q3 2025 · Sep 30, 2024 −$117.62M
Net Income Q3 2025 · Sep 30, 2024 −$154.36M
Operating Income Q3 2025 · Sep 30, 2025 −$131.27M
Operating Income Q3 2025 · Sep 30, 2025 −$269.41M
Operating Income Q3 2025 · Sep 30, 2024 −$133.51M
Operating Income Q3 2025 · Sep 30, 2024 −$184.03M
Revenue Q3 2025 · Sep 30, 2025 $1.44B
Revenue Q3 2025 · Sep 30, 2025 $4.36B
Revenue Q3 2025 · Sep 30, 2024 $1.45B
Revenue Q3 2025 · Sep 30, 2024 $4.54B